Aripiprazole: here's the fair price
This is what US pharmacies pay, on average, for aripiprazole. Use it to spot a fair cash price, and feel good about asking for one.
Aripiprazole 5 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Aripiprazole 5 Mg Tablet. Pharmacies pay about $3.50 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| ARIPIPRAZOLE 5 MG TABLETGeneric | $0.12 per tablet or capsule | $3.50 | 10/21/2026 |
| ARIPIPRAZOLE 10 MG TABLETGeneric | $0.12 per tablet or capsule | $3.56 | 10/21/2026 |
| ARIPIPRAZOLE 2 MG TABLETGeneric | $0.12 per tablet or capsule | $3.62 | 10/21/2026 |
| ARIPIPRAZOLE 15 MG TABLETGeneric | $0.13 per tablet or capsule | $4.01 | 10/21/2026 |
| ARIPIPRAZOLE 20 MG TABLETGeneric | $0.18 per tablet or capsule | $5.45 | 10/21/2026 |
| ARIPIPRAZOLE 30 MG TABLETGeneric | $0.18 per tablet or capsule | $5.48 | 10/21/2026 |
| ARIPIPRAZOLE 1 MG/ML SOLUTIONGeneric | $0.40 per mL | n/a | 10/21/2026 |
| ARIPIPRAZOLE ODT 15 MG TABLETGeneric | $1.81 per tablet or capsule | $54.37 | 10/21/2026 |
| ARIPIPRAZOLE ODT 10 MG TABLETGeneric | $2.42 per tablet or capsule | $72.63 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS AND USAGE Aripiprazole is indicated for the treatment of: • Schizophrenia • Irritability Associated with Autistic Disorder • Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. The oral formulations are indicated for: • Schizophrenia (14.1) • Irritability Associated with Autistic Disorder (14.4) • Treatment of Tourette’s disorder (14.5)
Common side effects (FDA label)
6 ADVERSE REACTIONS Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The following adverse reactions are discussed in more detail in other sections of the labeling: • Increased Mortality in Elderly Patients with Dementia-Related Psychosis [see Boxed Warning and Warnings and Precautions (5.1)] • Cerebrovascular Adverse Events, Including Stroke [see Warnings and Precautions (5.2)] •...
Drug interactions (from the label)
7 DRUG INTERACTIONS Dosage adjustment due to drug interactions (7.1): Factors Dosage Adjustments for Aripiprazole Known CYP2D6 Poor Metabolizers Administer half of usual dose Known CYP2D6 Poor Metabolizers and strong CYP3A4 inhibitors Administer a quarter of usual dose Strong CYP2D6 or CYP3A4 inhibitors Administer half of usual dose Strong CYP2D6 and CYP3A4 inhibitors Administer a quarter of usual dose Strong CYP3A4 inducers Double usual dose over 1 to 2 weeks 7.1 Drugs Having Clinically Important Interactions with Aripiprazole Table 25: Clinically Important Drug Interactions with Aripiprazole: Concomitant Drug Name or Drug Class Clinical Rationale Clinical Recommendation Strong CYP3A4...
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS • Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-Related Psychosis: Increased incidence of cerebrovascular adverse reactions (e.g., stroke, transient ischemic attack, including fatalities) (5.2) • Neuroleptic Malignant Syndrome: Manage with immediate discontinuation and close monitoring (5.4) • Tardive Dyskinesia: Discontinue if clinically appropriate (5.5) • Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes that include hyperglycemia/diabetes mellitus, dyslipidemia, and body weight gain (5.6) o Hyperglycemia/Diabetes Mellitus: Monitor glucose regularly in patients with and at risk for diabetes (5.6) o...
Source: FDA drug label via openFDA, label effective 2026-03-05. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.